Loading data for SEPN — first visit, this takes a few seconds.
Septerna, Inc. (SEPN)
NasdaqGM: SEPN
· Real-Time Price · USD
36.75
-0.05 (-0.14%)
At close: Sep 04, 2026, 3:59 PM
36.75
+0.00%
After-hours: 7:30 PM
The price, the headline numbers and the latest news, in one place.
Septerna, Inc. (SEPN) Stock Price, Analysis & Data
-0.14% (1D)
| Bid | 28.35 |
| Market Cap | 1.72B |
| Revenue (ttm) | 98.9M |
| Net Income (ttm) | -24.2M |
| 0.00 | |
| -0.53 | |
| n/a | |
| -18.93 | |
| P/B (ttm) | 4.36 |
| P/S (ttm) | 17.35 |
| Earnings Date | Nov 9, 2026 |
| Ask | 49.92 |
| Volume | 199,663 |
| Avg. Volume (20D) | 440,212 |
| Open | 36.57 |
| Previous Close | 36.80 |
| Day's Range | 36.57 - 37.59 |
| 52-Week Range | 13.67 - 51.10 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About SEPN
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 negative allosteric modulator (NAM) for chronic spo...
Industry Biotechnology
Sector Healthcare
IPO Date Oct 25, 2024
Employees 123
Stock Exchange NasdaqGM
Ticker Symbol SEPN
Website https://septerna.com
Financial Performance
In 2025, Septerna's revenue was 45.95M, an increase of 4,174.51% compared to the previous year's 1.08M. Earnings were -48.88M, a decrease of -31.92%.
Financial StatementsEarnings Surprise
Septerna has released their quarterly earnings on Aug 10, 2026:
- Revenue of $26.52M misses estimates by $0, with 12010.96% YoY growth.
- EPS of -0.29 exceeds estimates by 0.20, with 48.21% YoY growth.
Septerna, Inc. is scheduled to release its earnings on Nov 9, 2026, during market hours.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2